SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-244029
Filing Date
2021-08-12
Accepted
2021-08-12 10:20:01
Documents
3
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d162546d8k.htm 8-K 17771
2 EX-99.1 d162546dex991.htm EX-99.1 59664
3 GRAPHIC g162546dsp3.jpg GRAPHIC 5301
  Complete submission text file 0001193125-21-244029.txt   86100
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 211165873
SIC: 2834 Pharmaceutical Preparations